Endocrine and Metabolic Medicine Flashcards
Which hypoglycaemic agents are indicated in patients at risk of/with established CVD or CCF?
SGT2 inhibitor (e.g. dapagliflozin)
Which hypoglycaemic agents are indicated in patients with low risk of CVD or CCF?
DPP-4 inhibitors (e.g. sitagliptin, saxagliptin, linagliptin, and alogliptin)
TZDs (Pioglitazone)
Sulphonylureas (e.g. Gliclazide, glipizide)
Which side effects are associated with sulfonylureas (e.g. gliclazide)?
Hypoglycaemia
Weight gain
GI upset
Hypersensitivity
Which side effects are associated with incretin analogues (e.g. exanatide)?
Weight loss
Reduced hepatic fat accumulation
Hypoglycaemia
Nausea
Which side effects are associated with pioglitazone?
Weight gain
Fluid retention
What are the contraindications of pioglitazone?
CCF
Bladder cancer
Liver impairmentW
Which hypoglycaemic drug should be given if Q Risk score > 10%?
SGLT2 inhibitors
Which disorder is phaeochromocytoma associated with?
MEN II
Which investigation is used to diagnose pheochromocytoma?
24 hour urinary metanephrines
Which metabolic abnormality is seen in Cushing’s syndrome?
Hypokalaemia metabolic alkalosis
Which TFT pattern is seen in thyrotoxicosis (e.g. Grave’s disease)?
Low TSH
High free T4
Which biochemical pattern is seen in primary hyperparathyroidism?
High calcium
Low phosphate
High/normal PTH
Which biochemical pattern is seen in secondary hyperparathyroidism?
Chronic disease (e.g. CKD)
Low calcium
High phosphate
Compensatory increased PTH
Which biochemical pattern is seen in tertiary hyperparathyroidism?
Parathyroid hyperplasia
High calcium
High PTH
How is primary hyperparathyroidism treated?
Total parathyroidectomy